Proactive signal detection is a welcome step change in drug safety
Safety signal detection in post-market drug monitoring has changed little since the discipline was first introduced following the 1950s thalidomide tragedy.
But now smart new technology applied to robust, standardised real-world data, from sources including electronic medical records and healthcare claims, is set to make proactive signal detection a reliable reality. ArisGlobal’s Elizabeth Smalley explains.
Safety signal monitoring has changed little from when the practice was first introduced around 70 years ago in response to the thalidomide tragedy.
Check out the rest of this feature here
Source link
#Healthcare #flare #PharmaTimes
